Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-04-21 @ 11:30 AM
Study NCT ID:
NCT03222167
Status:
UNKNOWN
Last Update Posted:
2017-08-07
First Post:
2017-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
Sponsor:
Institute Of Cardiology & Internal Diseases, Kazakhstan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-08
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-17
First Submit QC Date:
None
Study First Post Date:
2017-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-04
Last Update Post Date:
2017-08-07
Last Update Post Date Type:
ACTUAL